Ümmügül ÜYETÜRK, Fatma KAPLAN EFE, Rıdvan ERTEN, Büşragül YILMAZ, Mehmet POYRAZER, Atacan ARAS

EVALUATION OF THE GENERAL DEMOGRAPHIC CHARACTERISTICS OF COLON CANCER PATIENTS: IS THERE A DIFFERENCE BETWEEN MALE AND FEMALE PATIENTS?

Objectives: Colon cancer (CC) is seen in both sexes at the third frequency, and it is the cause of cancer-related deaths at the second frequency despite the advances in diagnosis and treatment. This study, it was aimed to evaluate the patients diagnosed with CC and their general demographic features in Bolu. Materials and Methods: CC patients' gender, age, body mass index (BMI), the primary location of the tumor, pathological diagnosis, grade, staging, location of metastasis and treatments administered were recorded retrospectively. Results: Those diagnosed with CC constituted16.54% of all cancer patients during the study period. 199(60.49%) of 329 patients included in the study were male, and 130 (39.51%) were female. The median diagnosis age in men and women was 64 years, the maximal age range of diagnosis was 60-69 years (32.66% and 32.22%, respectively). It was found that 6.53% of men and 26.15% of women were obese. The pathological diagnosis of 317 (96.35%) of the patients was adenocarcinoma, and the highest Grade 2 tumors subsisted (48.63%) (p= 0.696). The most diagnosed stage was stage III in men (36.68%) and stage II in women (38.46%) (p=0.044). While the appeal with the metastatic stage was 25.13% in men, it was seen at 17.69% in women (p=0.044). Conclusion: In Bolu, CC is among the cancers in the early stage diagnostic screening program. It is important to increase the training and participation in these programs and to provide healthy nutrition and exercise training to avoid obesity which plays an important role, especially in women, in CC etiology. In addition, prospective studies should be carried out to prevent data loss and to reach healthy statistical results in our country.

PDF

___

1. Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145-64 (doi:10.3322/caac.21601).
2. Tarasiuk A, Mosinska P, Fichna J. The mechanisms linking obesity to colon cancer: An overview. Obes Res Clin Pract. 2018;12(3):251-9 (doi: 10.1016/j.orcp.2018.01.005).
3. Zhang YB, Pan XF, Chen J, et al. Combined lifestyle factors, incident cancer, and cancer mortality: a systematic review and meta-analysis of prospective cohort studies. Br J Cancer. 2020;122(7):1085-93 (doi:10.1038/s41416-020-0741-x).
4. Micu BV, Vesa ŞC, Pop TR, Micu CM. Evaluation of prognostic factors for 5 year-survival after surgery for colorectal cancer. Ann Ital Chir. 2020;91: p. 41-8.
5. Gültekin M, Boztaş G. Türkiye kanser istatistikleri. Sağlık Bakanlığı, Türkiye Halk Sağlığı Kurumu, 2014 [Internet]. https://hsgm.saglik.gov.tr/tr/kanser-istatistikleri. (Accessed: 10.05.2021).
6. Siegel RL, Fedewa SA, Anderson WF, et al. Colorectal Cancer Incidence Patterns in the United States, 1974-2013. J Natl Cancer Inst. 2017;109(8) (doi:10.1093/jnci/djw322).
7. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1;136(5):E359-86 (doi: 10.1002/ijc.29210).
8. Schoen RE, Razzak A, Yu KJ, et al. Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer. Gastroenterology. 2015;149(6):1438-45 e1 (doi:10.1053/j.gastro.2015.07.055).
9. Liu S, Zheng R, Zhang M, Zhang S, Sun X, Chen W, Incidence and mortality of colorectal cancer in China. Chin J Cancer Res. 2015;27:22-8 (doi: 10.3978/j.issn.1000-9604.2015.02.01).
10. Şahin NŞ, Üner BA, AydınM, Akçan A, Gemalmaz A, Dişçigil, G, et al. Aydın merkez ilçede kolorektal kanser taramasına ilişkin bilgi, tutum ve engeller. Türk Aile Hek Derg. 2015;19(1):37-48.
11. Türkoğlu A, Çetinkaya Z, Girgin M, Ayten R, Kanat BH, Binnetoğlu K, et al. Kolorektal kanserlerde prognostik faktörler. Dicle Tıp Dergisi. 2014;41(4):724-31 (doi:10.5798/diclemedj.0921.2014.04.0507).
12. Karahalios A, English DR, Simpson JA. Weight change and risk of colorectal cancer: a systematic review and meta-analysis. Am J Epidemiol. 2015;181(11):832-45 (doi:10.1093/aje/kwu357).
13. Zeren S, Bayhan Z, Koçak C, Ekici MF, Düzgün ŞA. The Effect of Overweight Status on Total and Metastatic Number of Harvested Lymph Nodes During Colorectal Surgery. Dicle Medical Journal / Dicle Tip Dergisi. 2016;43(1) (doi:10.5798/diclemedj.0921.2016.01.0653).
14. Buron Pust A, Alison R, Blanks R, et al. Heterogeneity of colorectal cancer risk by tumour characteristics: Large prospective study of UK women. Int J Cancer. 2017;140(5):1082-90 (doi:10.1002/ijc.30527).
15. Loree JM, Pereira AAL, Lam M, et al. Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes. Clin Cancer Res. 2018;24(5):1062-72 (doi:10.1158/1078-0432.CCR-17-2484).
16. Turan E, Yalçın BM, Yücel İ, Ünal M. İlk kez tanı konan kolorektal kanser hastalarının epidemiyolojik özellikleri. Turk Aile Hekimliği Dergisi. 2012;16:169-77.
17. Phiphatpatthamaamphan, K, Vilaichone R. Colorectal cancer in the central region of Thailand. Asian Pac J Cancer Prev. 2016;17(7):3647-50.
18. Awad H, Abu-Shanab A, Hammad N, Atallah A, Abdulattif M. Demographic features of patients with colorectal carcinoma based on 14 years of experience at Jordan University Hospital. Ann Saudi Med. 2018;38(6):427-32 (doi:10.5144/0256-4947.2018.427).
19. Gress, DM, Edge SB, Greene FL, et al. Principles of cancer staging. American College of Surgeons. 2017(8):3-30 (doi:10.1007/978-3-319-40618-3_1).
20. Badawi M, Abdelaal W, Abbas N, et al. Immunohistochemical expression of CD4+ and CD8+ tumorinfiltrating lymphocytes in colorectal carcinoma. Journal of The Arab Society for Medical Research. 2019;14(2):3-30 (doi:10.4103/jasmr.jasmr_22_19).
21. Bayar B, Yılmaz KB, Akıncı M, Şahin A, Kulaçoğlu H. An evaluation of treatment results of emergency versus elective surgery in colorectal cancer patients. Ulus Cerrahi Derg. 2016;32(1): 11–7 (doi:10.5152/UCD.2015.2969).
22. Karamchandani DM, Chetty R, King TS, Liu X, Westerhoff M, Yang Z, et al., Challenges with colorectal cancer staging: results of an international study. Mod Pathol. 2020 Jan;33(1):153-163(doi: 10.1038/s41379-019-0344-3).
23. Elferink MA, van der Vlugt M, Meijer GA, Lemmens VE, Dekker E. Colorectal carcinoma in the Netherlands: the situation before and after population surveillance. Ned Tijdschr Geneeskd. 2014;158:A7699.
24. Fiorentini G, Sarti D, Nani R, Aliberti C, Fiorentini C, Guadagni S. Updates of colorectal cancer liver metastases therapy: review on DEBIRI. Hepat Oncol. 2020 Jan 21;7(1):HEP16 (doi: 10.2217/hep-2019- 0010).
25. Riihimaki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;6:29765 (doi:10.1038/srep29765).
26. Hugen N, van de Velde CJH, de Wilt JHW, Nagtegaal ID. Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Ann Oncol. 2014 Mar;25(3):651-7( doi: 10.1093/annonc/mdt591).
27. Altin O, Alkan M. Risk factors associated with anastomotic leakage in patients operated due to colorectal tumours. Med Glas (Zenica). 2019;16(2) (doi:10.17392/1013-19).
28. Üreyen O, İlhan E, Dadalı E, et al. Evaluation of Factors Associated with Anastomotic Leakage in Colorectal Surgery. Turkish Journal of Colorectal Disease. 2018;28(3):129-35 (doi:10.4274/tjcd.53386).
29. Kumar S, Burney IA, Zahid KF, D Souza PC, Belushi MA, Mufti TD, et al. Colorectal cancer patient characteristics, treatment and survival in Oman—a single center study. Asian Pac J Cancer Prev. 2015;16(12):4853-8 (doi: 10.7314/apjcp.2015.16.12.4853).
30. Ünal NG, Coşgun G, Korkut M, et al. Ege Üniversitesi Tıp Fakültesi veri tabanındaki kolorektal kanserli olguların epidemiyolojik ve genel sağ kalım özellikleri. Ege Tıp Dergisi. 2019:68-77 (doi:10.19161/etd.668311).